These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8581359)

  • 1. Deleterious effect of formycin A on tumor islet cells.
    Rasschaert J; Tanigawa K; Malaisse WJ
    Biochem Mol Med; 1995 Apr; 54(2):138-41. PubMed ID: 8581359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulinotropic action of formycin A.
    Malaisse WJ; Sener A; Gruber HE; Erion MD
    Biochem Med Metab Biol; 1994 Oct; 53(1):22-7. PubMed ID: 7857678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effect of formycin A upon the hydrolysis of phosphoinositides in perifused pancreatic islets.
    Ulusoy S; Sener A; Malaisse WJ
    Cell Signal; 1995 Nov; 7(8):821-6. PubMed ID: 8593250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of the cationic, bioelectrical and secretory responses to formycin A in pancreatic islet cells.
    Lebrun P; Renström E; Antoine MH; Bokvist K; Holmquist M; Rorsman P; Malaisse WJ
    Pflugers Arch; 1996 Jan; 431(3):353-62. PubMed ID: 8584428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The riddle of formycin A insulinotropic action.
    Malaisse WJ; Lebrun P; Pirotte B; Van Poelje PD; Viñambres C; Villanueva-Peñacarrillo ML; Valverde I; Gäbel J; Rorsman P
    Biochem Mol Med; 1996 Feb; 57(1):47-63. PubMed ID: 8812726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted effect of formycin A and non-glucidic nutrients upon insulin release in islets from rats with hereditary or acquired non-insulin-dependent diabetes.
    Giroix MH; Zhang TM; Leclercq-Meyer V; Sener A; Portha B; Malaisse WJ
    Acta Diabetol; 1995 Oct; 32(3):198-202. PubMed ID: 8590791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic action of 2-deoxy-D-glucose tetraacetate in tumoral pancreatic islet cells.
    Malaisse WJ; Delvaux A; Rasschaert J; Kadiata MM
    Cancer Lett; 1998 Mar; 125(1-2):45-9. PubMed ID: 9566695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of propranolol on the blood sugar immunoreactive blood insulin in a patient with insulinoma].
    Neri V; Bartorelli A; Faglia G
    Acta Diabetol Lat; 1969; 6(4):809-19. PubMed ID: 4321785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conservative treatment of pancreatic insulin-secreting insulinoma].
    Muszyński J
    Pol Arch Med Wewn; 1978 Mar; 59(3):361-6. PubMed ID: 209417
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin secretion in vivo and in vitro from transplantable NEDH rat insulinoma and derived clonal RINm5F cell line.
    Flatt PR; DeSilva M; Swanston-Flatt SK; Marks V
    Diabetes Res; 1987 Oct; 6(2):85-90. PubMed ID: 2827934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cytotoxic drugs and inhibitors of insulin secretion on a serially transplantable rat insulinoma and cultured rat insulinoma cells.
    Flatt PR; Swanston-Flatt SK; Tan KS; Marks V
    Gen Pharmacol; 1987; 18(3):293-7. PubMed ID: 3032737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells.
    D'Ambra R; Surana M; Efrat S; Starr RG; Fleischer N
    Endocrinology; 1990 Jun; 126(6):2815-22. PubMed ID: 1693563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 8-azaadenosine and formycin on cell lethality and the synthesis and methylation of nucleic acids in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Biochem Pharmacol; 1982 Oct; 31(20):3207-14. PubMed ID: 7150349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour formation and insulin secretion by clonal RINm5F cells following repeated subcutaneous transplantation in NEDH rats.
    Flatt PR; DeSilva MG; Swanston-Flatt SK; Powell CJ; Marks V
    J Endocrinol; 1988 Sep; 118(3):429-37. PubMed ID: 2846737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.
    Murray-Lyon IM; Eddleston AL; Williams R; Brown M; Hogbin BM; Bennett A; Edwards JC; Taylor KW
    Lancet; 1968 Oct; 2(7574):895-8. PubMed ID: 4176152
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma.
    Curnow RT; Carey RM; Taylor A; Johanson A; Murad F
    N Engl J Med; 1975 Jun; 292(26):1385-6. PubMed ID: 166308
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of hypoglycemic attacks and insulin release by propranolol in a patient with metastatic malignant insulinoma.
    Shaklai M; Aderka D; Blum I; Laron Z; Asherov J; Doron M; Atsmon A; Pinkhas J
    Diabete Metab; 1977 Sep; 3(3):155-8. PubMed ID: 199483
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis and treatment of pancreatic insulin-secreting tumors. Apropos of 2 cases observed personally].
    Luyckx A; Zahnd G; Lefebvre P
    Acta Clin Belg; 1969; 24(2):93-108. PubMed ID: 4322921
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulus-secretion coupling of arginine-induced insulin release: metabolism of L-arginine and L-ornithine in tumoral islet cells.
    Malaisse WJ; Blachier F; Mourtada A; Camara J; Albor A; Valverde I; Sener A
    Mol Cell Endocrinol; 1989 Nov; 67(1):81-91. PubMed ID: 2558931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA synthesis in starfish embryos: developmental consequences of its inhibition by formycin.
    Isomura H; Itoh N; Ikegami S
    Biochim Biophys Acta; 1989 Apr; 1007(3):343-9. PubMed ID: 2467690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.